Gabriella Gálffy

3.3k total citations
84 papers, 1.3k citations indexed

About

Gabriella Gálffy is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology. According to data from OpenAlex, Gabriella Gálffy has authored 84 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 44 papers in Physiology and 22 papers in Oncology. Recurrent topics in Gabriella Gálffy's work include Asthma and respiratory diseases (39 papers), Inhalation and Respiratory Drug Delivery (17 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers). Gabriella Gálffy is often cited by papers focused on Asthma and respiratory diseases (39 papers), Inhalation and Respiratory Drug Delivery (17 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers). Gabriella Gálffy collaborates with scholars based in Hungary, United States and Austria. Gabriella Gálffy's co-authors include Lilla Tamási, György Losonczy, Kamal A. Mohammed, Veena B. Antony, András Bikov, Ildikó Horváth, Nasreen Noor, Balázs Döme, Veronika Müller and Zsófia Lázár and has published in prestigious journals such as Nature Communications, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Gabriella Gálffy

80 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gabriella Gálffy Hungary 22 626 468 326 317 156 84 1.3k
Keiichiro Akamatsu Japan 24 778 1.2× 492 1.1× 493 1.5× 211 0.7× 359 2.3× 58 1.6k
Hideki Inoue Japan 23 789 1.3× 653 1.4× 295 0.9× 283 0.9× 129 0.8× 68 1.5k
Mitsuyoshi Utsugi Japan 22 379 0.6× 282 0.6× 239 0.7× 365 1.2× 374 2.4× 53 1.3k
Soon Seog Kwon South Korea 23 510 0.8× 487 1.0× 79 0.2× 232 0.7× 314 2.0× 82 1.3k
Ute Oltmanns Germany 18 717 1.1× 429 0.9× 125 0.4× 189 0.6× 166 1.1× 28 1.2k
Kaoru Hamada Japan 18 317 0.5× 312 0.7× 116 0.4× 209 0.7× 223 1.4× 36 952
Suzanne Traves Canada 23 679 1.1× 613 1.3× 149 0.5× 317 1.0× 471 3.0× 32 1.5k
Sohei Makino Japan 18 440 0.7× 723 1.5× 103 0.3× 164 0.5× 246 1.6× 99 1.3k
Gurpreet K. Singhera Canada 19 399 0.6× 278 0.6× 63 0.2× 259 0.8× 276 1.8× 53 1.1k
Mikio Kataoka Japan 23 494 0.8× 434 0.9× 103 0.3× 239 0.8× 204 1.3× 66 1.2k

Countries citing papers authored by Gabriella Gálffy

Since Specialization
Citations

This map shows the geographic impact of Gabriella Gálffy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriella Gálffy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriella Gálffy more than expected).

Fields of papers citing papers by Gabriella Gálffy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriella Gálffy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriella Gálffy. The network helps show where Gabriella Gálffy may publish in the future.

Co-authorship network of co-authors of Gabriella Gálffy

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriella Gálffy. A scholar is included among the top collaborators of Gabriella Gálffy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriella Gálffy. Gabriella Gálffy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reinmuth, Niels, Óscar Juan, Dariusz M. Kowalski, et al.. (2024). Novel Combinations of Immunotherapies or DNA Damage Repair Inhibitors in Platinum-Refractory Extensive-Stage Small Cell Lung Cancer: The Phase II BALTIC Study. Clinical Cancer Research. 30(18). 4055–4067. 5 indexed citations
2.
Gálffy, Gabriella, et al.. (2024). Metabolic pathways from the gut metatranscriptome are associated with COPD and respiratory function in lung cancer patients. Frontiers in Cellular and Infection Microbiology. 14. 1381170–1381170.
3.
Farkas, Árpád, et al.. (2024). Comparative study of the inhalation parameters of COPD patients through NEXThaler® and Ellipta® dry powder inhalers. Respiratory Medicine. 224. 107576–107576. 1 indexed citations
4.
Heymach, John V., David H. Harpole, Tetsuya Mitsudomi, et al.. (2023). Abstract CT005: AEGEAN: A phase 3 trial of neoadjuvant durvalumab + chemotherapy followed by adjuvant durvalumab in patients with resectable NSCLC. Cancer Research. 83(8_Supplement). CT005–CT005. 55 indexed citations
5.
Seelbinder, Bastian, Zoltán Lohinai, Ruben Vazquez-Uribe, et al.. (2023). Candida expansion in the gut of lung cancer patients associates with an ecological signature that supports growth under dysbiotic conditions. Nature Communications. 14(1). 2673–2673. 26 indexed citations
6.
7.
Ni, Yueqiong, Zoltán Lohinai, Yoshitaro Heshiki, et al.. (2021). Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients. The ISME Journal. 15(11). 3207–3220. 86 indexed citations
8.
Molnár, Dávid, et al.. (2021). Prevalence of Asthma and Its Associating Environmental Factors among 6–12-Year-Old Schoolchildren in a Metropolitan Environment—A Cross-Sectional, Questionnaire-Based Study. International Journal of Environmental Research and Public Health. 18(24). 13403–13403. 11 indexed citations
9.
Gálffy, Gabriella, et al.. (2021). Allergic Rhinitis Therapy Decisions During a Routine Consultation: A Multicenter, Cross-Sectional Survey. Journal of Asthma and Allergy. Volume 14. 335–345. 8 indexed citations
10.
Seelbinder, Bastian, Yueqiong Ni, János Tamás Varga, et al.. (2021). Gut microbiome functionality might be associated with exercise tolerance and recurrence of resected early-stage lung cancer patients. PLoS ONE. 16(11). e0259898–e0259898. 15 indexed citations
11.
Weissenbruch, Ranny van, Ludger Klimek, Gabriella Gálffy, et al.. (2020). <p>MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis</p>. Journal of Asthma and Allergy. Volume 13. 633–645. 4 indexed citations
12.
Molnár, Dávid, et al.. (2020). Prevalence of allergic rhinitis, related comorbidities and risk factors in schoolchildren. Allergy Asthma and Clinical Immunology. 16(1). 98–98. 32 indexed citations
13.
Horváth, Péter, Zsófia Lázár, Gabriella Gálffy, et al.. (2020). Circulating P-Selectin Glycoprotein Ligand 1 and P-Selectin Levels in Obstructive Sleep Apnea Patients. Lung. 198(1). 173–179. 16 indexed citations
14.
15.
Bogos, Krisztina, Zoltán Kiss, Gabriella Gálffy, et al.. (2019). Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary. Frontiers in Oncology. 9. 1051–1051. 18 indexed citations
16.
Bikov, András, Imre Barta, Gabriella Gálffy, et al.. (2018). Assessment of the circulating klotho protein in lung cancer patients. Pathology & Oncology Research. 26(1). 233–238. 16 indexed citations
17.
Gálffy, Gabriella, et al.. (2017). [Role of pembrolizumab in the treatment of non-small cell lung cancer (NSCLC)].. PubMed. 61(1). 107–110. 2 indexed citations
18.
Müller, Veronika, et al.. (2016). Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data. International Journal of COPD. 11. 93–93. 15 indexed citations
19.
Gálffy, Gabriella, et al.. (2013). Inhaler Competence and Patient Satisfaction with Easyhaler®: Results of Two Real-Life Multicentre Studies in Asthma and COPD. Drugs in R&D. 13(3). 215–222. 23 indexed citations
20.
Nasreen, Najmunnisa, et al.. (2000). Talc Induces Apoptosis in Human Malignant Mesothelioma Cells In Vitro. American Journal of Respiratory and Critical Care Medicine. 161(2). 595–600. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keiichiro Akamatsu Breakdown of academic impact, for papers by Hideki Inoue Breakdown of academic impact, for papers by Mitsuyoshi Utsugi Breakdown of academic impact, for papers by Soon Seog Kwon Breakdown of academic impact, for papers by Ute Oltmanns Breakdown of academic impact, for papers by Kaoru Hamada Breakdown of academic impact, for papers by Suzanne Traves Breakdown of academic impact, for papers by Sohei Makino Breakdown of academic impact, for papers by Gurpreet K. Singhera Breakdown of academic impact, for papers by Mikio Kataoka
Rankless by CCL
2026